Archimed buys another diagnostics business; EQT names private capital co-heads; HIG Capital in action

HIG Capital has acquired a majority stake in Protos.

We’ve got an exclusive interview to start the day, as we speak to Vincent Guillaumot, managing partner at Archimed, about his firm’s latest acquisition, announced this morning: BioVendor.

Next, we’ve got news of some new promotions at EQT, as the firm names a pair of private capital co-heads to replace Per Franzén, who is becoming CEO.

Share this